Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 24;58(10):1349-1361.
doi: 10.1007/s43465-024-01239-8. eCollection 2024 Oct.

Chondrogenic Potential of Umbilical Cord-Derived Mesenchymal Stromal Cells: Insights and Innovations

Naveen Jeyaraman  1 , Madhan Jeyaraman  1   2   3 , Sathish Muthu  3   4   5 , Sangeetha Balaji  6 , Swaminathan Ramasubramanian  6 , Bishnu Prasad Patro  7
Affiliations
Review

Chondrogenic Potential of Umbilical Cord-Derived Mesenchymal Stromal Cells: Insights and Innovations

Naveen Jeyaraman et al. Indian J Orthop. .

Abstract

Background: The advent of tissue engineering and regenerative medicine has introduced innovative approaches to treating degenerative and traumatic injuries, particularly in cartilage, a tissue with limited self-repair capabilities. Among the various stem cell sources, umbilical cord-derived mesenchymal stromal cells (UC-MSCs) have garnered significant interest due to their non-invasive collection, minimal ethical concerns, and robust regenerative potential, particularly in cartilage regeneration.

Methods: A comprehensive literature review was conducted using multiple databases, including PubMed, Scopus, Web of Science, and Google Scholar. Search terms focused on "umbilical cordderived mesenchymal stromal cells," "chondrogenesis," "cartilage regeneration," and related topics. Studies published in the past two decades were included, with selection criteria emphasizing methodological rigor and relevance to UC-MSC chondrogenesis. The review synthesizes findings from various sources to provide a thorough analysis of the potential of UC-MSCs in cartilage tissue engineering.

Results: UC-MSCs exhibit significant chondrogenic potential, supported by their ability to differentiate into chondrocytes under specific conditions. Recent advancements include the development of biomaterial scaffolds and the application of genetic engineering techniques, such as CRISPR/Cas9, to enhance chondrogenic differentiation. Despite these advancements, challenges remain in standardizing cell isolation techniques, scaling up production for clinical use, and ensuring the long-term functionality of regenerated cartilage.

Conclusion: UC-MSCs offer a promising solution for cartilage regeneration in the field of regenerative medicine. Ongoing research is focused on overcoming current challenges through the use of advanced technologies, including bioreactors and gene editing. Collaborative efforts among researchers, clinicians, and bioengineers are essential to translating the potential of UC-MSCs into effective clinical therapies, which could significantly advance tissue regeneration and therapeutic innovation.

Keywords: Chondrogenesis; Mesenchymal stromal cells; Regenerative medicine; Tissue engineering; Umbilical cord.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.

Similar articles

See all similar articles

References

    1. Zakrzewski, W., Dobrzyński, M., Szymonowicz, M., & Rybak, Z. (2019). Stem cells: Past, present, and future. Stem Cell Research & Therapy,10, 68. 10.1186/s13287-019-1165-5 - PMC - PubMed
    1. Mebarki, M., Abadie, C., Larghero, J., & Cras, A. (2021). Human umbilical cord-derived mesenchymal stem/stromal cells: A promising candidate for the development of advanced therapy medicinal products. Stem Cell Research & Therapy,12(1), 152. 10.1186/s13287-021-02222-y - PMC - PubMed
    1. Pan, X., Li, X., Zhang, L., Wu, F., Zhang, Q., Xu, S., et al. (2023). Umbilical cord mesenchymal stem cells relieve osteoarthritis in rats through immunoregulation and inhibition of chondrocyte apoptosis. Scientific Reports,13(1), 14975. 10.1038/s41598-023-42349-x - PMC - PubMed
    1. Muthu, S., Jeyaraman, M., Jain, R., Gulati, A., Jeyaraman, N., Prajwal, G. S., et al. (2021). Accentuating the sources of mesenchymal stem cells as cellular therapy for osteoarthritis knees—a panoramic review. Stem Cell Investigation. 10.21037/sci-2020-055 - PMC - PubMed
    1. Russo, E., Caprnda, M., Kruzliak, P., Conaldi, P. G., Borlongan, C. V., & La Rocca, G. (2022). Umbilical cord mesenchymal stromal cells for cartilage regeneration applications. Stem Cells International,2022, 2454168. 10.1155/2022/2454168 - PMC - PubMed

LinkOut - more resources